Regarding this type of bioengineering involving white blood cells , I am not qualified to place this news within the landscape of previous scientific pathways, but because of the high cost of personalized targeting
for each patient, the article does offer the fairy godmother wish that a Saviour would come along to replicate this personalized patient success with an off the shelf methodology. at much lower cost.
Yet the aforementioned I referred to, is still a lavish wish, involving macrophages, as the substance of all this possible road to success to eliminate cancer has not gone beyond in vivo.
